EU BROADENS INQUIRY INTO DRUG MARKET Source:International Herald Tribune Date: 14-May-2008
Author: James Kanter
European antitrust investigators are expanding the scope of a major inquiry into the €484 billion pharmaceutical market in a bid to determine whether companies are blocking generics makers from getting less-expensive medicines to market quickly.
Full text
WEAK SALES PROMPT PFIZER TO CANCEL DIABETES DRUG Source:International Herald Tribune Date: 19-Oct-2007
Author: Alex Berenson
Pfizer said Thursday that it would stop selling Exubera, its inhaled insulin, less than two years after introducing the drug. Despite Pfizer's heavy promotion, Exubera's sales were minuscule, with prescriptions amounting to less than 1 percent of the insulin market.
Full text
U.S. PRESCRIPTION DRUG PRICES RISING AT A SLOWER PACE Source:International Herald Tribune Date: 21-Sep-2007
Author: Stephanie Saul
As overall health care costs continue to rise sharply in the United States, prescription drugs have emerged as a surprising exception - in large part thanks to generic drug companies in places like Israel and India.
Full text
